Searched over 200M research papers for "diabetes mechanism"
10 papers analyzed
These studies suggest that type 2 diabetes involves defective insulin secretion, impaired insulin signaling, and insulin resistance, with molecular mechanisms, protein signaling pathways, and epigenetic factors contributing to the disease and its complications.
20 papers analyzed
Diabetes, particularly Type 2 Diabetes Mellitus (T2DM), is a complex metabolic disorder characterized by chronic hyperglycemia. The primary mechanisms underlying T2DM involve defective insulin secretion by pancreatic β-cells and insulin resistance in insulin-sensitive tissues. This article delves into the molecular and cellular mechanisms that contribute to the development and progression of diabetes.
In T2DM, pancreatic β-cells fail to secrete adequate insulin in response to glucose levels. This defect is a critical factor in the disease's pathophysiology. The synthesis and release of insulin are tightly regulated processes, and any disruption can lead to metabolic imbalances.
Insulin resistance is a hallmark of T2DM and the metabolic syndrome. It occurs when insulin-sensitive tissues, such as muscle, fat, and liver, do not respond appropriately to insulin. This resistance is often due to defects in the insulin signaling pathway, particularly involving the insulin receptor substrate (IRS) proteins and downstream signaling molecules like Akt and Foxo1 .
The IRS proteins play a pivotal role in insulin signaling. Upon insulin binding to its receptor, IRS proteins are phosphorylated, activating the PI3K/Akt pathway. This pathway is crucial for glucose uptake and metabolism. Dysregulation of IRS proteins, through mechanisms such as serine phosphorylation, impairs this signaling cascade, leading to insulin resistance .
Inflammatory and metabolic stresses activate several kinases, including IKKβ, JNK, and mTOR, which induce serine phosphorylation of IRS proteins. This modification disrupts normal insulin signaling, contributing to insulin resistance. These kinases integrate signals from various stressors, exacerbating the condition.
Glucose fluctuations, not just constant hyperglycemia, play a significant role in diabetic complications. These fluctuations lead to the production of reactive oxygen species (ROS), which damage cellular components and disrupt signaling pathways, including protein kinase C and nuclear factor-κB .
Epigenetic changes, such as DNA methylation and histone modifications, also contribute to the long-term complications of diabetes. These changes can alter gene expression in target cells, perpetuating vascular dysfunction and other complications despite glycemic control.
Diabetes is closely linked to cardiovascular disorders, including accelerated atherosclerosis and cardiomyopathy. Excessive ROS production in diabetic cardiovascular cells leads to various pathogenic signaling pathways, contributing to these conditions. Insulin resistance further exacerbates cardiovascular risks by increasing fatty acid flux and oxidative stress in cardiomyocytes.
Understanding the intricate mechanisms of diabetes, from insulin secretion and resistance to the role of glucose fluctuations and ROS, is crucial for developing effective therapeutic strategies. Targeting key signaling pathways and addressing both genetic and environmental factors can help mitigate the progression and complications of diabetes. Continued research in these areas holds promise for better management and treatment of this pervasive metabolic disorder.
Most relevant research papers on this topic